Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Conditions: Cervix Cancer; HPV Infection; Cervical High Grade Squamous Intraepithelial Lesion; HIV Infections Interventions: Diagnostic Test: Xpert HPV; Diagnostic Test: S5 DNA methylation classifier Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; Mexican National Institute of Public Health; Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Conditions: Cervix Cancer; HPV Infection; Cervical High Grade Squamous Intraepithelial Lesion; HIV Infections Interventions: Diagnostic Test: Xpert HPV; Diagnostic Test: S5 DNA methylation classifier Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; Mexican National Institute of Public Health; Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Conditions: Cervix Cancer; HPV Infection; Cervical High Grade Squamous Intraepithelial Lesion; HIV Infections Interventions: Diagnostic Test: Xpert HPV; Diagnostic Test: S5 DNA methylation classifier Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; Mexican National Institute of Public Health; Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Conditions: Cervix Cancer; HPV Infection; Cervical High Grade Squamous Intraepithelial Lesion; HIV Infections Interventions: Diagnostic Test: Xpert HPV; Diagnostic Test: S5 DNA methylation classifier Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; Mexican National Institute of Public Health; Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Conditions: Cervix Cancer; HPV Infection; Cervical High Grade Squamous Intraepithelial Lesion; HIV Infections Interventions: Diagnostic Test: Xpert HPV; Diagnostic Test: S5 DNA methylation classifier Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; Mexican National Institute of Public Health; Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Conditions: Cervix Cancer; HPV Infection; Cervical High Grade Squamous Intraepithelial Lesion; HIV Infections Interventions: Diagnostic Test: Xpert HPV; Diagnostic Test: S5 DNA methylation classifier Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; Mexican National Institute of Public Health; Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
